CFTR
CFTR (cystic fibrosis transmembrane conductance regulator) is an ABC transporter-class ion channel that conducts chloride[3] and thiocyanate[4] ions across epithelial cell membranes.
Products for CFTR
- Cat.No. Product Name Information
-
GC31665
(R)-BPO-27
(R)-BPO-27, the R enantiomer of BPO-27, is a potent, orally active and ATP-competitive CFTR?inhibitor with an?IC50 of 4 nM.
-
GC69812
(R)-Elexacaftor
(R)-VX-445
(R)-Elexacaftor is the enantiomer of Elexacaftor (Compound 1) and comes from Compound 37 in patent WO2018107100A1. It is a corrector of cystic fibrosis transmembrane conductance regulator (CFTR), with an EC50 value of 0.29 uM for CFTR dF508.
-
GC67767
(R)-Olacaftor
(R)-VX-440
-
GC62513
(R)-Posenacaftor sodium
(R)-PTI-801 sodium
(R)-Posenacaftor (R)-PTI-801) sodium is the R enantiomer of Posenacaftor.
-
GC70934
(R)-Vanzacaftor
(R)-Vanzacaftor ((R)-VX-121) is a regulator of cystic fibrosis transmembrane conduction regulator (CFTR).
-
GC72112
Astressin 2B TFA
Astressin 2B TFA is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively.
-
GC68723
Bamocaftor
VX-659
Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore the function of F508del-CFTR protein. Bamocaftor can be used in combination with Tezacaftor and Ivacaftor for research on cystic fibrosis.
-
GC30537
BPO-27 racemate
BPO-27 racemate is a potent CFTR inhibitor with an IC50 of 8 nM.
-
GC63976
Cavosonstat
N91115
Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor.
-
GC35667
CFTR corrector 1
VX-445
CFTR corrector 1 (VX-445, Compound 1) is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR).
-
GC34532
CFTR corrector 2
CFTR corrector 2 is a cystic fibrosis transmembrane conductance corrector (CFTR), extracted from patent US20140274933.
-
GC67939
CFTR corrector 4
-
GC62510
CFTR corrector 6
CFTR corrector 6 is a potent potentiator of Cystic Fibrosis Transmembrane conductance Regulator (CFTR).
-
GC68282
CFTR corrector 8
-
GC65029
CFTR corrector 9
CFTR corrector 9 (compound 42) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator.
-
GC14421
CFTRinh-172
CFTR(inh)172, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor 172
CFTRinh-172 was identified as a potent and selective blocker of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel. CFTRinh-172 inhibits Cl- current in wild-type, G551D, and G1349D CFTR with Ki value of 0.5μM.
-
GC67925
Crinecerfont hydrochloride
SSR-125543 hydrochloride; SSR-125543A
-
GC64121
Dirocaftor
-
GC68397
Galicaftor
ABBV-2222; GLPG-2222
-
GC19169
GLPG1837
ABBV-974
GLPG1837 is a potent and reversible CFTR potentiator, with EC50s of 3 nM and 339 nM for F508del and G551D CFTR, respectively.
-
GC36149
GLPG2451
GLPG2451 is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator, which effectively potentiates low temperature rescued F508del CFTR with an EC50 of 11.1 nM.
-
GC17804
GlyH-101
GlyH101, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor II
CFTR Inhibitor II
-
GC63353
Icenticaftor
Icenticaftor (QBW251) is an orally active CFTR channel potentiator, with EC50s of 79 nM and 497 nM for F508del and G551D CFTR, respectively.
-
GC11229
IOWH-032
CFTR inhibitor
-
GC10296
Ivacaftor (VX-770)
VX 770
Ivacaftor (VX-770) (VX-770) is a potent and orally bioavailable CFTR potentiator, targeting G551D-CFTR and F508del-CFTR with EC50s of 100 nM and 25 nM, respectively.
-
GC12489
Ivacaftor benzenesulfonate
VX-770 benzenesulfonate;VX 770 benzenesulfonate;VX770 benzenesulfonate;Kalydeco benzenesulfonate
A CFTR potentiator
-
GC13316
Ivacaftor hydrate
VX-770 hydrate;VX 770 hydrate;VX770 hydrate;Kalydeco hydrate
A CFTR potentiator
-
GC70634
Ivacaftor-d4
Ivacaftor-d4 (VX-770-d4) is the deuterium labeled-Ivacaftor .
-
GC64678
K41498 TFA
K41498 TFA is a potent and highly selective CRF2?receptor antagonist with Ki?values of 0.66 nM, 0.62 nM and 425 nM for human CRF2α, CRF2β?and CRF1 receptors respectively.
-
GC14914
KM 11060
Corrects F508del-CFTR trafficking
-
GC63479
Navocaftor
GLPG 3067; ABBV-3067
Navocaftor (GLPG 3067), as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1).
-
GC68015
NJH-2-057
-
GC64358
Olacaftor
VX-440
Olacaftor (VX-440) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator extracted from patent US9782408.
-
GC10288
PG 01
CFTR mutants potentiator
-
GC62522
Posenacaftor sodium
PTI-801 sodium
Posenacaftor (PTI-801) sodium is a cystic fibrosis transmembrane regulator (CFTR) protein modulator that corrects the folding and trafficking of?CFTR?protein.
-
GC17616
PPQ-102
CFTR Inhibitor IV, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor IV
potent CFTR inhibitor
-
GC12346
PTC124(Ataluren)
PTC 124;PTC-124
PTC124(Ataluren) (PTC124) is an orally available CFTR-G542X nonsense allele inhibitor.
-
GC34745
PTI-428
PTI-428
PTI-428 (PTI-428) is a specific cystic fibrosis transmembrane conductance regulator (CFTR) amplifier.
-
GC67789
SRI-37240
-
GC69942
SRI-41315
SRI-41315 is a potent eRF1 degrading agent.
-
GC73522
Tezacaftor-d4
VX-661-d4
Tezacaftor-d4 (VX-661-d4) is the deuterium-labeled Tezacaftor , a F508del CFTR corrector.
-
GC72897
UCCF-853
UCCF-853 is a CFTR modulator.
-
GC70933
Vanzacaftor
Vanzacaftor is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR) for researching cystic fibrosis.
-
GC14920
VX-661
Tezacaftor
VX-661 (VX-661) is a second F508del CFTR corrector and help CFTR protein reach the cell surface.
-
GC15455
VX-809
VX 809; VX809; Lumacaftor; VRT 826809
VX-809 (VX-809; VRT 826809) is a CFTR modulator that corrects the folding and trafficking of CFTR protein.